


































Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 1 

Review Article 

Analytical Method Development and Validation 

Rutik Nitin Patil1, Bhupendra L Deore2, Darshan Ganesh gurav1 

From, 1M.pharm, 2PHD & M Pharm, Department of Quality Assurance, A.R.A College of Pharmacy, Dhule, India. 

ABSTRACT  

The main objective of the pharmaceutical business is to consistently and economically create goods with the requisite features and 

quality. The process of finding, creating, and assessing pharmaceutical formulations requires the creation of a methodology. The 

primary goal of this review article is to examine how the medication development and validation process was carried out, from the 

beginning of the formulation to the end of the commercial batch. Reliability of the results is essential whenever an analytical method 

is used to generate results for an array of samples related to medicine. In the pharmaceutical sector, good manufacturing practice 

(GMP) rules and good laboratory practices (GLP) are adhered to by means of defined validation policies, forms of validation, and 

validation criteria. Validation is crucial to the efficient operation of the pharmaceutical sector. Validation was done everywhere, from 

the raw material to the final, stable state. The procedure was appropriately designed, and the validation parameters—specificity, 

accuracy, quantitation, ruggedness, robustness, and system appropriateness testing—are specified in terms of limit of detection 

(LOD), limit of quantitation (LOQ), robustness, and ruggedness with reference to specific drug examples. Both the methodology and 

evaluation of stability make use of all the validation parameters. 

Key words: Analytical validation, Method Development, Validation on HPLC, Separation technique, Various Parameters 

hese drugs may be entirely new or partially 

structurally modified versions of ones currently on the 

market. The aim of every analytical measurement is to 

generate data that is consistent, accurate, and reliable. 

Validated analytical methods are necessary to do this. Any 

legitimate analytical approach must include a means of 

assessing the precision, dependability, and uniformity of the 

statistical investigation utilizing its findings of method 

validation. Furthermore, the validation of analytical 

techniques is a must around numerous laws in addition to 

criteria pertaining to facilities. The date a medication is added 

to pharmaceutical protocols and the moment it was initially 

made available to consumers usually coincide [1]. 

In such circumstances, the pharmacopoeias could not have 

specified the requirements and testing methodologies for these 

drugs. Thus, it may be possible to develop fresher analytical 

methods for these drugs. In the process of finding, developing, 

and producing medications, analytical methods are crucial. 

Drug combination products, also known as combination 

products, combine the therapeutic benefits of two or more 

medications into a single item in order to fulfil the needs of 

individuals whose work is not formerly treated by them. This 

requires the invention and development of analytical methods. 

The analytical chemist in charge of creating and verifying 

Access this article online 

 

Received –  20th July 2024 

Initial Review –  28th September 2024 

Accepted – 28th October 2024 

Quick Response Code 

analytical procedures may face significant challenges as a 

result of these combination products. To verify the 

identification, purity, potency, and effectiveness of 

pharmaceutical items, regulatory laboratories employ 

legitimate test techniques that are produced by these 

procedures. Identification and measurement of contaminants 

belong to one of the most crucial steps in creating 

pharmaceutical procedures for quality and safety [1]. 

 Basic criteria for new method development for drug 

analysis  

a. The medication is unlikely to be listed as official in any 

pharmacopoeias. 

b. Analytical methods for a medicine may not be permitted in 

publishing under any specific creation aspect due to 

interference through formulation excipients.  

c. Due to patent laws, appropriate analytical techniques for 

the drug could not be accessible.  

d. There could not be adequate analytical techniques 

obtainable for assessing the drug through your system. 

 Various reasoning for analytical technique 

Analytical techniques have progressed, and during analytical 

analyses, HPLC procedures produce vast amounts of data. 

Even though HPLC is a flexible separation method with many 

__________________________________________________ 

Correspondence to: Rutik Nitin Patil. Department of Quality 

Assurance, A.R.A College of Pharmacy, Dhule, India. 

Email: rutik.patil57@gmail.com 

T 

mailto:rutik.patil57@gmail.com


Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 2 

uses, its many variables, which must be precisely adjusted 

before each run, can occasionally make the procedure 

dangerous. Consequently, it becomes imperative to 

comprehend these methods on a deeper level. Furthermore, 

the process of optimizing Multiple variables that need to be 

controlled at the same time in order to achieve the required 

separations, such as the mobile phase's pH, buffer 

concentration, rate of flow, column temperature, detector raise 

length, etc [2]. The chemometric technique is highlighted in 

all of these studies as a new instrument in the arena of 

pharmaceutical analysis. The use of laboratory patterns to 

establish design spaces—a crucial element of the quality with 

the design approach of analytical methods—was recently 

covered by Rozet et al [3]. 

 

 

 

 

 

 

 

Figure 1: Life cycle of the analytical method [4] 

 

Objectives: 

1. Development and Validation of Analytical Methods: From 

the formulation phase all the way up to the manufacturing 

of commercial batches, analytical techniques are essential. 

To make sure that these techniques yield accurate and 

trustworthy findings, they must be researched and verified. 

2. Importance of Validation: Validation guarantees that 

analytical procedures satisfy specified requirements for 

system appropriateness, ruggedness, robustness, limit of 

detection (LOD), limit of quantitation (LOQ), accuracy, 

specificity, and precision. These criteria are necessary to 

guarantee the quality of pharmaceuticals. 

3. Regulatory Bodies: Validation procedures follow GMP 

guidelines and are recorded. In order to guarantee the 

security, effectiveness, and caliber of their goods, 

pharmaceutical companies must abide by these rules. 

4. Stages of Validation: Testing is done on raw materials and 

final products in every stage of the production method to 

ensure their stability. This all-encompassing strategy 

guarantees that the procedure is validated and satisfies 

necessary requirements. 

5. Method Development: In order to assure that analyses are 

sensitive, selective, and capable of reliably delivering 

accurate findings under a variety of the settings window, 

proper method development entails improving and refining 

these processes. 

6. Routine and Stability Testing: Validation parameters are 

used in stability testing as well as routine analysis, as the 

latter evaluates the stability of the final product and the 

pharmaceutical ingredient that is active (API) over time 

[5,6,7].  

METHOD DEVELOPMENT 

The development and validation of analytical methods are 

crucial to the process of making discoveries and producing 

medications. These techniques are employed to guarantee 

drug goods' authenticity, potency, purity, and effectiveness. 

When creating procedures, there are several things to take into 

account. Initially, data on the analyte's physiochemical 

properties (pKa, log P, and solubility) are recorded, and if UV 

detection is required, the suitable detection mode is chosen, 

and if UV detection is needed, the appropriate mode of 

detection is determined. The validation of a stability-

indicating HPLC method constitutes the principal focus of 

analytical development efforts. Trying to isolate and quantify 

the primary active ingredient, any reaction impurities, any 

synthetic intermediates that are accessible, and any degradants 

are the objectives of the HPLC-method [8, 9]. 

Criteria for the Development of New Analytical Method: 

The identification of the product is predicated on the 

evaluation procedure of pharmaceuticals. The addition of a 

medicine to pharmacopoeias and its commercial release date 

frequently fall on the same day. This is brought on by new 

toxicity reports, patient resistance developing over time, 

potential concerns about the prolonged and increased use of 

these medicines, and the launch of more potent drugs by rival 

companies. The novel medication or combination of 

medications might not be classified in any pharmacopoeia. It's 

possible that analytical methods for quantifying the drug in 

body fluids are unavailable. The present tests may require the 

use of pricey materials and chemicals. It may also need time-

consuming and sometimes unreliable extraction and 

separation processes [10, 11]. 

 HPLC method development  

1. Recognizing the drug molecule's physicochemical 

characteristics. 

When developing a technique, a medicinal molecule's 

physicochemical characteristics are crucial. The physical 

characteristics of the drug molecule, such as its pH, polarity, 

solubility, and pKa, must be studied in order to build a 

method. One of a compound's physical characteristics is 

polarity. It aids in the determination of the mobile phase's 

solvent and composition by the analyzer. The polarity of 

molecules that are provides an explanation for their solubility. 

Solvents that are polar, like water, and nonpolar, like benzene, 

do not combine. pH is characterized as the negative logarithm 



Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 3 

of the h+ ion concentration to base 10. The pH scale is -

log10[H3O+]. Sharp, symmetrical peaks are consistently 

observed in HPLC when ionizable analytes are selected at the 

proper pH. Quantitative analysis requires sharply symmetrical 

heights in order to ensure low relative standard deviations 

between injections, minimal detection limits, and predictable 

retention durations [12, 13]. 

2. The chromatographic conditions chosen: Selection of 

column: 

In method development, choosing the stationary phase or 

column is the first and most crucial step. Without a reliable, 

high-performing column, it is difficult to design a robust and 

repeatable procedure. Stable and repeatable columns are 

crucial to prevent issues with irreproducible sample retention 

through method development. All samples may normally be 

separated using a C8 or C18 column, which is highly 

recommended. These columns are built from carefully 

purified, lower-acid silica as well as being particularly 

developed for the separation from basic chemicals [14]. The 

primary ones are the column diameters, the silica substrate 

qualities, and the bonded stationary phase features. For a 

number of physical reasons, silica-based packing is preferred 

in the majority of current HPLC column [15]. 

3. Improving the mobile stage 

a) Buffer Selection: 

The intended pH determines which buffer to use. When 

reversed phase on silica-based packaging, the usual pH range 

is 2 to 8. Since buffers regulate pH best at their pKa, it is 

critical that the buffer's pKa be somewhat near the intended 

pH. Generally speaking, pick a buffer with a pKa value. 

General consideration for buffer selection: 

a. Phosphate seems to be more soluble in methanol/water 

than in acetonitrile or THF/water. 

b. Due to their significant hygroscopicity, some salt buffers 

may result in chromatographic changes, including greater 

tailing of basic compounds and perhaps different 

selectivity. 

c. Ammonium salts tend to dissolve more readily in 

organic/H20 mobile phases 

[16].                                                                 

b) Effect of pH 

The pKa of the ionizable analyte should be used as a guide to 

determine the proper mobile-phase pH. By doing this, it is 

guaranteed that the desired analyte is ionized or neutral. One 

of the most useful tools in the chromatographer's toolbox is 

the ability to modify the pH of the mobile phase. This feature 

enables retention and selectivity to be changed 

simultaneously, offering a tactical way to maximize separation 

conditions, especially for important component pairings in the 

sample. In order to customize chromatographic conditions and 

provide the required separation results, pH modification is 

essential [17]. 

c) Effect of organic modifier: 

In reverse phase HPLC, choosing the kind of organic modifier 

is rather straightforward. Methanol and acetonitrile are the 

most common options (THF is rarely used). Since it would not 

be possible to elute every component between k (retention 

factor) 1 and ten using a single solvent strength during 

isocratic conditions, gradient elution is typically used with 

complicated multicomponent samples [18]. 

Choose the detector 

The HPLC's detector is an essential component. The chemical 

composition of the analytes, potential interference, required 

detection limit, detector availability, and/or detector cost all 

affect the detector choice. The UV-visible detector is a UV-

visible dual-wavelength absorbance detector that is flexible 

and stays HPLC. The high sensitivity of this detector is 

required for routine UV-based applications, such as low-level 

impurity detection and quantitative analysis. The photodiode 

array (PDA) detector offers advanced optical detection with 

aqueous analytical HPLC, preparative HPLC, or LC/MS 

system solutions. The developments in optics and integrated 

software allow for the achievement of high spectrum and 

chromatic sensitivity. The ideal choice for analysing 

components with little to no UV absorption is the Refractive 

Index (RI) detecting device because of its exceptional 

sensitivity, stability, and reproducibility. The Multi-

Wavelength Fluorescence Detector can measure minute 

quantities of target chemicals and offers high sensitivity and 

selectivity fluorescence detection [19, 20]. 

 Technique of separation 

a) Isocratic separations 

Analyte-eluent and analyte-stationary-phase interactions 

remain stable over the course of the run when there is an 

isocratic, constant eluent composition. This also guarantees 

equilibrium conditions in the column and the real velocity of 

compounds flowing through the column. Despite the low 

separation power—the amount of compounds that might be 

resolved—this increases the predictability of isocratic 

separations. The peak capacity is modest, and the resulting 

peak widens as the length of time the component is kept on 

the column [21]. 

b) Gradient separation 

A system's separation power is greatly increased by gradient 

separation, mostly due to the abrupt rise in apparent efficiency 

(reduction in peak width). Peak width decreases in the 

situation when the chromatographic zone's tail is constantly 

affected by a more potent eluent composition. Peak width is a 

function of gradient slope, which measures how quickly the 

eluent composition changes. Shifting the Gradient Since it 

might not be possible to elute every component between k 



Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 4 

(retention factor) from 1 to 10 using only one solvent's 

strength during isocratic conditions, gradient elution is used 

for complicated multicomponent samples. If the ratio is less 

than 0.25, isocratic would be sufficient; if it is greater than 

0.25, gradient will be advantageous [22, 23]. 

Preparing samples for technique development 

It is necessary for the drug material under analysis to be stable 

in solution (diluent). The solutions should be prepared in 

amber flasks during the early stages of method development 

until it is shown that the active ingredient is stable at room 

temperature and does not deteriorate under typical laboratory 

circumstances. It is advised to filter the sample solution using 

0.22 / 0.45 µm pore-size filtration to remove any particles. For 

HPLC analysis, filtration is a preventative maintenance 

technique [24, 25]. 

Optimization of methods 

Determine the shortcomings of approach and use experimental 

design to strengthen it. Evaluate the approach's effects on 

different samples, equipment setups, and environmental 

conditions. This iterative process aids in the methodology's 

improvement and ensures that high-performance liquid 

chromatography (HPLC) analysis is robust, reliable, and 

applicable under a variety of conditions [26]. 

Validation of methods 

The procedure of laboratory testing is carried out to show that 

an analytical method's performance characteristics match the 

demands of the planned analytical application is known as 

validation. Any new or revised procedure has to be validated 

to make sure it consistently yields reproducible and 

trustworthy results, regardless of whether it is performed by 

several operators in various laboratories using the same 

Utilizing equipment that satisfies requirements, is operational, 

functional, and accurately calibrated is crucial to the 

validation process. Analytical methods are carefully examined 

during the validation process, after which they are either 

approved for use or rejected if they don't match the necessary 

standards. This ensures the correctness and dependability for 

statistical results in multiple uses [27, 28].                        

Validation 

Analyst interpretation is used to validate methods because 

there is no industry standard for assay validation. Industry 

committees, regulatory bodies, and the International 

Conference on Harmonization (ICH) of technical standards for 

the registration of medicines in human use have all placed a 

great deal of emphasis on method validation. Methods that 

have been verified by multiple laboratories are offered by the 

US Environmental Protection Agency (US EPA), the 

Resource Conservation and Recovery Act (RCRA), the 

American Association of Official Analytical Chemists 

(AOAC), the US Environmental Protection Agency (USP), 

and other scientific associations [29]. The Food and Drug 

Administration (US FDA) has put forward criteria on the 

submission of analytical and sample data for the purpose of 

technique validation. Particular criteria have been established 

by the United States Pharmacopoeia (USP) for technique 

validation and substance assessment [30]. 

The four most prevalent types of analytical processes are the 

focus of the debate on their validity. 

1. Tests for identification. 

2. Measurements that quantify the amount of contaminants. 

3. Limit assessments for impurity control. 

4. Quantitative analyses of the active ingredient in drug 

substance or product samples, as well as other specific 

components within the drug product [31]. 

Various need to be validated. 

1. Whenever the condition for which the technique has been 

validated changes, such as an instrument with new 

features, prior to its introduction into regular usage. 

2. Whenever modifications are made to the procedure that go 

beyond its initial parameters [32]. 

Various parameters are given below:                              

a) Accuracy                      

Accuracy is the level to which the value being measured 

agrees with the true or recognized value. In practical terms, 

accuracy is the discrepancy between the actual value and the 

mean value that was produced. To ascertain accuracy, the 

process is applied to samples with known analyte 

concentrations. Accuracy is computed as a share of the 

analyser retrieved by the assay based on test results. It is 

commonly expressed as the assay-based recovery of the 

additional analyte levels that are known; this indicates the 

degree to which the real values are captured by the analytical 

method [33, 34]. 

b) Precision 

In analytical procedures, precision is associated with the 

degree of agreement and dispersion between several 

measurements taken under particular circumstances from 

different samples of the same homogenous material. A crucial 

factor in determining the repeatability of the entire analytical 

process is precision. Precision consists of two elements: 

intermediate precision and repeatability. Repeatability is the 

difference between two measurements made by one analyst 

using the same tool These precision assessment components 

guarantee a thorough comprehension of the analytical 

method's repeatability and dependability across various 

operators and settings [35, 36]. 

 %RSD=std dev.*100/mean 

c) Linearity 



Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 5 

A technique for analysis is said to be linear if it can yield test 

results that are precisely matched to the concentration of any 

analyte in the sample. One way to demonstrate linearity on the 

test material is to dilute a standard stock solution, or another 

method is to weigh each component separately in synthetic 

blends of the test product. The linearity is confirmed via 

injecting five to six times at least five standards at doses 

between 80 and 120 percent of the estimated concentration 

range. A precise mathematical computation must determine 

the proportionality of the reaction, or it must be proportional 

right away to the analyte concentrations.  

d) Limit of Detection [LOC] 

Analysing an analyte's threshold for detection using a single 

method is the easiest approach to quantifying it in a sample 

when it can be identified but not accurately measured. Is 

typically used to express the LOD. Determination: For non-

instrumental approaches, the lowest level at which the analyte 

may be reliably detected is established, and samples with 

known concentrations of the analyte are analysed to determine 

the detection limit. ICH Standards: The ICH outlines a 

standard procedure that involves comparing the observed 

signal between samples that have known analyte 

concentrations and those that are blank. It is determined what 

the analyte's minimal concentration is at which it may be 

accurately identified. LOD computations pertaining to 

instrument sensitivity 

LOD(mg/L)=3×Noise/Signal 

The linearity samples' lowest concentration A 2:1 or 3:1 

signal-to-noise ratio is often considered adequate [37, 38, 39]. 

e) Limit of Quantification (LOQ) 

Minimal level of analyte for the purpose of evaluating low 

analyte levels in test matrices; this limit functions as a 

quantitative test parameter. The quantitation limit serves as a 

threshold for accurate quantitative measurements on analytical 

procedures and is essential for detecting contaminants and/or 

impurities in samples [40]. 

A single analytical procedure's limit of quantitation, also 

known as its quantitation limit, is the smallest quantity of 

analyte in an experiment that is capable of being quantitatively 

measured with appropriate precision and accuracy. The LOQ 

is often determined from a S/N ratio (10:1) for analytical 

processes that display baseline noise, and it is typically 

validated by injecting standards that both meet an acceptable 

percent absolute standard deviation and this S/N ratio [41, 42]. 

f) Specificity 

Every development step should see a specificity in the 

analytical method. The method should be able to conclusively 

determine if the target analyte is present in the presence of 

every anticipated component, including sample blank peaks, 

excipients, degradants, and sample matrix [43]. To ascertain 

how long each medication would remain in the sample and in 

a combination, specificity testing was done. When the 

standard medications were tested separately, their respective 

retention times were found to be 3.750 min for nitazoxanide 

and 1.533 min for ofloxacin. When the drugs were tested 

together, their respective retention times were found to be 

3.760 min with nitazoxanide and 1.542 min for ofloxacin. 

g) Range 

The analytical techniques range is the range of a compound's 

concentration inside the sample between its highest and 

minimum levels at which the linearity, precision, and accuracy 

of the analytical method can be shown to be sufficient. The 

range is often given in percentages or parts per million, much 

like the test results generated by the analytical technique. 

1. 80–1200% of the test concentration is used in the 

experiment. 

2. Consistency of content and test concentration between 70–

130% 

3. Impurities: 120% of the recommended level is the 

reporting threshold for impurities. 

test and impurities: up to 120% of the test-specific 

reporting criteria. 

4. Q-20% solubility to 120% [44]. 

 

a)  

b)  

c)  

a) Linear                                                  b) Non-Linear 

Figure 2. Plot for ranges of an analytical technique 

h) Robustness 

The robustness of an analytical method is defined as the 

degree of repeatability of test results via the same samples 

analysed under various standard test conditions, which could 

include different operators, different laboratories, and possibly 

different operational along with environmental conditions, 

while staying within the assay's defined parameters. Testing 

for ruggedness is typically suggested when the process will be 

used in several labs. Ruggedness is evaluated by calculating 

the degree of outcome repeatability as a function of the test 

variable. This reproducibility could be used to gauge the 

analytical method's ruggedness by comparing it to the assay's 

accuracy under typical conditions [45]. 

i) System suitability determination 

Tests for system compatibility are an essential component of 

liquid chromatographic techniques. They are employed to 

confirm that the chromatographic systems detection 

sensitivity, resolution, and repeatability are sufficient for the 

intended analysis. The foundation of the testing is the idea that 



Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 6 

the tools, electronics, processes involved in the analysis, and 

materials to be examined all work together as a cohesive 

system that is capable of being assessed as such. 

Measurements have been made of peak resolution, number of 

theoretical plates can, peak tailing, and capacity to assess the 

applicability of the used technique [45]. 

j) Forced Degradation Studies 

In order to purposefully deteriorate the sample, stress 

experiments or forced degradation are conducted. By 

producing possible degradation products, these investigations 

assess an analytical method's capacity to quantify an active 

chemical and its breakdown products independently. Drug 

materials are subjected to acid, base, heat, light, and oxidizing 

agents during method validation, resulting in 10% to 30% 

degradation of the active ingredient. Forced degradation 

studies are conducted for various reasons, such as developing 

and validating stability-indicating methodology, identifying 

drug substances as well as drug product degradation 

pathways, and differentiating between degradation products in 

formulations related to drug substances and those related to 

non-drug substances [45]. 

k) Stability Studies 

The durability of both samples and standards is determined 

during validation under typical circumstances, under typical 

storage settings, and occasionally within the instrument to 

ascertain whether specific storage conditions—such as 

refrigeration or light protection are required [45]. 

CONCLUSION 

The aim of every analytical measurement is to generate data 

that is consistent, accurate, and reliable. These techniques are 

employed to guarantee drug authenticity, potency, purity, and 

effectiveness. These state about various parameters and 

techniques, which shows that are suitable for the procedure 

and can be developed for the tests. In this article, we have 

discussed how validation was carried out with the use of 

specific validation parameters—including linearity, LOQ, 

LOD, range, robustness, and system suitability. In the 

pharmaceutical industry, validation is an essential technique 

that ensures quality is included in the processes that support 

drug development and production. It assures all parameters 

and conducts the phases of trails. 

REFERENCES  

1. FDA Guidance for Industry. Analytical Procedures and Method 

Validation, Chemistry, Manufacturing, and Controls 

Documentation, Center for Drug Evaluation and Research 

(CDER) and Center for Biologics Evaluation and Research 

(CBER). 2000:234 

2. Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, et al. 

Guidance for robustness/ruggedness tests in method validation. 

Journal of pharmaceutical and biomedical analysis. 2001; 24(5-

6):723-53. 

3. Rozet E, Lebrun P, Hubert P, et al. Design spaces for analytical 

methods. TrAC Trends in Analytical Chemistry. 2013; 42:157-

67. 

4. Chauhan A. harti Mittu B, Chauhan P (2015) Analytical Method 

Development and Validation: A Concise Review. J Anal Bioanal 

Tech. 2015; 6(233):2.  

5. Shabir GA, John Lough W, Arain SA, et al. Evaluation and 

application of best        practice in analytical method validation. 

Journal of liquid chromatography & related technologies. 2007; 

30(3):311-33. 

6. Sharma S, Goyal S, Chauhan K. A review on analytical method 

development and validation. International Journal of Applied 

Pharmaceutics. 2018; 10(6):8-15. 

7.  Castelino LJ, Narayanan VA, Fernandes SD, et al. Good clinical 

practices: an Indian perspective. Research journal of Pharmacy 

and Technology.    2018; 11(7):3209-15. 

8. Kavittha KY, Geetha G, Venkatnarayanan R. Development and 

validation of liquid chromatographic methods for the estimation 

of drugs in multi-component dosage forms. Pharmacie Globale. 

2012; 3(11):1. 

9. Sankar Rs. Text Book of Pharmaceutical Analysis. Rx 

publications; 2010. 

10. Shu YZ. Recent natural products based drug development: a 

pharmaceutical industry perspective. Journal of natural products. 

1998; 61(8):1053-71. 

11. Chin WW, Parmentier J, Widzinski M, et al. A brief literature 

and patent review of nanosuspensions to a final drug product. 

Journal of Pharmaceutical Sciences. 2014; 103(10):2980-99. 

12.  S. Sood, R. Bala, N.S. Gill, Method development and validation 

using HPLC technique – A review, Journal of Drug Discovery 

and Therapeutics 2 (22) 2014, 18- 24. 

13. Charde MS, Welankiwar AS, Kumar J. Method development by 

liquid chromatography with validation. International Journal of 

Pharmaceutical Chemistry. 2014; 4(02):57-61. 

14. Isane SP, Waghmare SA, Kamble HV. A Review on Method 

Development, Validation, Optimization and Applications of 

HPLC. 

15. Md Sabir A, Moloy M, Parminder BS. HPLC Method 

Development and Validatıon: A Review. Int Res J Pharm. 2013; 

4:39-46. 

16. Chandrul Kaushal K, Srivastava B. A process of method 

development: A chromatographic approach. J. Chem. Pharm. 

Res. 2010; 2(2):519-45. 

17. Lindholm J. Development and validation of HPLC methods for 

analytical and preparative purposes (Doctoral dissertation, Acta 

Universitatis Upsaliensis). 

18. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC method 

development. John Wiley & Sons; 2012 Dec 3. 

19. Dean JA. Analytical chemistry handbook. (No Title). 1995 Apr. 

20.  TROUBLESHOOTING L. Stability-Indicating Assays. LC• GC 

Europe. 2002 May: 274. 

21. Pirok BW, Gargano AF, Schoenmakers PJ. Optimizing 

separations in online comprehensive two‐dimensional liquid 

chromatography. Journal of separation science. 2018; 41(1):68-

98. 

22. Hong DD, Shah M. Development and validation of HPLC 

stability-indicating assays. Drugs and the Pharmaceutical 

Sciences. 2000; 107:329-84. 

23. Gassmann O, Reepmeyer G, Von Zedtwitz M. Leading 

pharmaceutical innovation. Berlin: Springer. https://doi. org/10. 

2008; 1007:978-3. 



Patil et al.                                                                                                 Analytical Method Development and Validation 

Online First                                                                                                                       Indian J Pharm Drug Studies | 7 

24. Br. Jay, J. Kelvin, and B. Pierre, Understanding and 

Implementing Efficient Analytical Methods Development and 

Validation, 2003. 

25. Huber L. Validation of analytical methods and processes. 

InPharmaceutical process validation 2003 Mar 27 (pp. 550-567). 

CRC Press. 

26. Mokhtar HI, Abdel-Salam RA, Hadad GM. Development of a 

fast high performance liquid chromatographic screening system 

for eight antidiabetic drugs by an improved methodology of in-

silico robustness simulation. Journal of Chromatography A. 

2015; 1399:32-44. 

27. Guidance R. Validation of chromatographic methods. Center for 

Drug Evaluation and Research (CDER), Washington. 1994; 2. 

28. ICH-Q2B. International Conference on Harmonization (ICH) of 

Technical Requirements for the Registration of Pharmaceuticals 

for Human Use, validation of analytical procedures: 

Methodology. 

29. G. Ramana Rao, S.S.N. Murthy, and P Khadgapathi, Gas 

Chromatography to Pharmaceutical Analysis, Eastern 

Pharmacist, 1987; 30(353): 35. 49.  

30. G. Ramana Rao, S.S.N. Murthy, and P. Khadgapathi, High 

Performance Liquid Chromatography and its Role in 

Pharmaceutical Analysis, Eastern Pharmacist, 1986; 29(346): 53. 

31. R.A. Day, and A.L, Underwood, Quantitative Analyses, (5th Ed., 

Prentice Hall, New Delhi, 1986. 

32. Macek K. Pharmaceutical applications of thin-layer and paper 

chromatography. (No Title). 1972. 

33. Raunig DL, McShane LM, Pennello G, et al. Quantitative 

imaging biomarkers: a review of statistical methods for technical 

performance assessment. Statistical methods in medical research. 

2015; 24(1):27-67. 

34. González AG, Herrador MÁ. A practical guide to analytical 

method validation, including measurement uncertainty and 

accuracy profiles. TrAC Trends in Analytical Chemistry. 2007; 

26(3):227-38. 

35. Ravisankar P, Rajyalakshmi G, Devadasu C, et al. Instant tips for 

right and effective approach to solve HPLC trouble shooting. 

Journal of chemical and pharmaceutical sciences. 2014; 7(3):259-

74 

36. Breaux J, Jones K, Boulas P. Analytical methods development 

and validation. Pharm. Technol. 2003; 1:6-13. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

37. Guideline IH. Validation of analytical procedures: text and 

methodology. Q2 (R1). 2005; 1(20):05. 

38. United States Pharmacopeial Convention. USP 33 NF 28: United 

States Pharmacopeia [and] National Formulary. Reissue. 

Supplement 2. a. United States Pharmacopeial Convention. 

39. Tiwari G, Tiwari R. Bioanalytical method validation: An updated 

review. Pharmaceutical methods. 2010; 1(1):25-38. 

40. Nirupa G, Tripathi UM. RP-HPLC analytical method 

development and validation for simultaneous estimation of two 

drugs nitazoxanide, ofloxacin and its pharmaceutical dosage 

forms. Int J ChemTech Res. 2012; 5(1):775-83. 

41. Pagare R, Aher S, Bachhav R. A Simple Analytical Method 

Development and Validation of Azilsartan Medoxomil in Bulk 

and Pharmaceutical Dosage Form. 1-9. 

42. Pharmacopeial Convention, Inc, 2440; 2003.Michel E. Swartz 

and Ira S Krull; Analytical method development and validation; 

Special Indian edition; Marcel Dekker, Inc.73-74. 

43. Dadhich B, Goyal R, Agarwal D. A Review On: Development 

and Validation of HPLC in Pharmaceutical Dosage Form. Asian 

Journal of Pharmaceutical Research and Development. 2020; 

8(4):110-21. 

44. United States Pharmacopeial Convention. USP 33 NF 28: United 

States Pharmacopeia [and] National Formulary. Reissue. 

Supplement 2. a. United States Pharmacopeial Convention. 

45. Alsante KM, Ando A, Brown R, et al. The role of degradant 

profiling in active pharmaceutical ingredients and drug products. 

Advanced drug delivery reviews. 2007; 59(1):29-37. 

 

 

 

 

 

 

 

How to cite this article: Patil RN, Deore BL, Gurav DG. 

Analytical Method Development and Validation. Indian J 

Pharm Drug Studies. 2024; Online First. 

Funding: None;                 Conflicts of Interest: None Stated 

 


	Objectives:
	1. Development and Validation of Analytical Methods: From the formulation phase all the way up to the manufacturing of commercial batches, analytical techniques are essential. To make sure that these techniques yield accurate and trustworthy findings,...
	2. Importance of Validation: Validation guarantees that analytical procedures satisfy specified requirements for system appropriateness, ruggedness, robustness, limit of detection (LOD), limit of quantitation (LOQ), accuracy, specificity, and precisio...
	3. Regulatory Bodies: Validation procedures follow GMP guidelines and are recorded. In order to guarantee the security, effectiveness, and caliber of their goods, pharmaceutical companies must abide by these rules.
	4. Stages of Validation: Testing is done on raw materials and final products in every stage of the production method to ensure their stability. This all-encompassing strategy guarantees that the procedure is validated and satisfies necessary requireme...
	5. Method Development: In order to assure that analyses are sensitive, selective, and capable of reliably delivering accurate findings under a variety of the settings window, proper method development entails improving and refining these processes.
	6. Routine and Stability Testing: Validation parameters are used in stability testing as well as routine analysis, as the latter evaluates the stability of the final product and the pharmaceutical ingredient that is active (API) over time [5,6,7].
	METHOD DEVELOPMENT

